Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-15 Purchase |
2021-06-16 6:20 pm |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
705,853 | $17 | $11,999,501 | 282,398 (Indirect) |
View |
| 2021-06-15 Purchase |
2021-06-16 6:17 pm |
Janux Therapeutics Inc. | JANX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director |
705,853 | $17 | $11,999,501 | 282,398 (Indirect) |
View |
| 2021-06-15 Purchase |
2021-06-16 6:11 pm |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
629,411 | $17 | $10,699,987 | 4,652,427 (Indirect Direct) |
View |
| 2021-06-15 Purchase |
2021-06-16 6:05 pm |
Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner |
629,411 | $17 | $10,699,987 | 4,479,492 (Indirect) |
View |
| 2021-06-15 Purchase |
2021-06-16 5:59 pm |
Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. 10% Owner |
629,411 | $17 | $10,699,987 | 8,866,709 (Indirect Direct) |
View |
| 2021-06-15 Purchase |
2021-06-16 5:21 pm |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2,941,176 | $17 | $49,999,992 | 1,048,406 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-15 Conversion |
2021-06-16 6:20 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
4,161,198 | $0 | 282,398 (Indirect) |
View |
| 2021-06-15 Conversion |
2021-06-16 6:17 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director |
4,161,198 | $0 | 282,398 (Indirect) |
View |
| 2021-06-15 Conversion |
2021-06-16 6:11 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
6,855,609 | $0 | 4,652,427 (Indirect) |
View |
| 2021-06-15 Conversion |
2021-06-16 6:05 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner |
14,325,514 | $0 | 4,479,492 (Indirect) |
View |
| 2021-06-15 Conversion |
2021-06-16 5:59 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. 10% Owner |
14,325,514 | $0 | 8,866,709 (Direct) |
View |
| 2021-06-15 Conversion |
2021-06-16 5:21 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
10,202,121 | $0 | 1,048,406 (Indirect) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:43 pm |
N/A 2031-06-09 |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director 10% Owner |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:40 pm |
N/A 2031-06-09 |
Janux Therapeutics Inc. | JANX | Simson Jake Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:37 pm |
N/A 2031-06-09 |
Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2021-06-10 7:35 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director |
0 | $0 | 2,336,911 (Indirect) |
View |
Ownership |
2021-06-10 7:32 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Bregua Corp 10% Owner |
0 | $0 | 3,690,427 (Direct) |
View |
Ownership |
2021-06-10 7:28 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. 10% Owner |
0 | $0 | 8,237,298 (Direct) |
View |
Ownership |
2021-06-10 7:24 pm |
N/A 2031-05-13 |
Janux Therapeutics Inc. | JANX | Godfrey Wayne Chief Medical Officer |
0 | $0 | 448,350 (Direct) |
View |
Ownership |
2021-06-10 7:22 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
0 | $0 | 2,336,911 (Indirect) |
View |
Ownership |
2021-06-10 7:18 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
0 | $0 | 4,215,166 (Direct) |
View |
Ownership |
2021-06-10 7:15 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
0 | $0 | 338,183 (Direct) |
View |
Ownership |
2021-06-10 7:12 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner |
0 | $0 | 8,237,298 (Indirect) |
View |
Ownership |
2021-06-10 7:10 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Heller Stefan Director |
0 | $0 | 96,075 (Direct) |
View |
Ownership |
2021-06-10 7:06 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director |
0 | $0 | 162,687 (Direct) |
View |
Ownership |
2021-06-10 7:05 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 5,729,468 (Indirect) |
View |
Ownership |
2021-06-10 7:04 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director |
0 | $0 | 96,075 (Direct) |
View |
Ownership |
2021-06-10 7:02 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer |
0 | $0 | 2,276,612 (Direct) |
View |